Diabetes is a metabolic disorder known to induce various complications in the eye, kidney, peripheral and central nervous system. In case of females the problem gets further aggravated as diabetes also impairs embryonic development during pregnancy and causes diabetic embryopathy. The high rate of birth defects associated with diabetic embryopathy is a significant public health problem in United States. Among the various malformations in diabetic embryopathy, neural tube defects (NTDs) are the most common complications. Many studies have shown that 50-70% of NTDs can be prevented by folic acid supplementation before and during pregnancy. However, complete protection by any drug or supplementation remains elusive. G-proteins (Gi/Go/Gz) have been reported to be involved in neural tube closing and knocking out of Rho GTPase (Rac1) causes exencephaly and spina bifida. Recent studies suggest that resveratrol improves insulin sensitivity, lowers plasma glucose, and increases mitochondrial capacity in diet-induced obese mice. This study investigated if resveratrol prevents diabetes-induced embryonic malformations. Using a rodent model of diabetic embryopathy we demonstrate that resveratrol (100 mg/kg body wt) administration to diabetic dams reduces blood sugar and improves lipid profile (Singh et al., Mol Nutr Food Res 2011, 55: 1-11) . It also prevents malformations such as NTDs in the embryos. Our immunohistology and biochemical assays further show that diabetes affects MAP kinase pathways while resveratrol prevents it. As MAP kinase pathways are also regulated by Rho GTPases (RhoA and Rac1), resveratrol may target Rho GTPase signaling to prevent neural tube defects. Gene-environment interactions influence embryonic development and diseases. Folic acid (FA) supplementation is used as a public health measure for prevention of birth defects. How FA interacts with genetic components during embryogenesis remains poorly defined mainly due to our inability to study FA-gene interactions in human development. Here, we utilize the power of mouse genetics and embryology to study the molecular interaction between FA and the Line 3 Poly (L3P) genetic component in mice. Under multi-generational low (2 ppm) FA diet, heterozygous females harboring L3P mutation undergo embryonic lethality. Importantly, L3P ± lethality is rescued under high (10 ppm) FA diet. We hypothesize that L3P ± female loss is due to defects in the maintenance of the inactivated X chromosome (Xi). As FA is a methyl donor for DNA methylation and DNA methylation is essential for Xi maintenance, FA may rescue Xi maintenance defects through the DNA methylation pathway. Here, we will define when L3P ± females are lost and if Xi maintenance defects underlie L3P ± female loss. Furthermore, we will examine if FA rescues Xi maintenance defects in L3P ± females and identify the L3P genetic component. In addition, we will identify genes downstream of L3P genetic component and FA pathway. Finally, we will examine the epigenetic changes that result from a multi-generational FA diet. Together, these studies will provide insights into the molecular mechanisms by which FA influences epigenetic processes during mammalian development. These studies are of relevance to human health considering US population-wide grain fortification with FA and maternal periconceptional use of FA to decrease the risks of birth defects. 
